Very recently, analysis of the p53 codon 72 Arg/Pro polymorphism identified the Pro/Pro phenotype as an independent marker of poor prognosis in neuroblastoma patients, and in vitro led to reduced levels of apoptosis in response to chemotherapy and irradiation (Cattelani et al., 2012). The gene discussed is TP53; the disease is neuroblastoma.